Get the Stockscreener App
1.57
1.88%
-0.03
Mainz Biomed N V stock is traded at $1.57, with a volume of 53,694.
It is down -1.88% in the last 24 hours and up +1.29% over the past month.
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.
See More
Previous Close:
$1.60
Open:
$1.62
24h Volume:
53,694
Relative Volume:
0.23
Market Cap:
$7.19M
Revenue:
$895.50K
Net Income/Loss:
$-26.30M
P/E Ratio:
-0.0239
EPS:
-65.5728
Net Cash Flow:
$-23.84M
1W Performance:
+1.29%
1M Performance:
+1.29%
6M Performance:
-57.57%
1Y Performance:
-84.67%
1-Day Range:
$1.535
$1.6254
1-Week Range:
$1.47
$1.68
52-Week Range:
$1.2801
$14.39
Mainz Biomed N V Stock (MYNZ) Company Profile
Name
Mainz Biomed N V
Sector
Industry
Phone
-
Address
-
Compare MYNZ with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MYNZ
Mainz Biomed N V
|
1.57 | 8.66M | 895.50K | -26.30M | -23.84M | -65.57 |
|
TMO
Thermo Fisher Scientific Inc
|
557.63 | 212.89B | 43.74B | 6.59B | 6.11B | 17.30 |
|
DHR
Danaher Corp
|
216.90 | 156.11B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
634.36 | 51.80B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
145.85 | 41.56B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
218.13 | 36.96B | 15.70B | 1.24B | 2.01B | 6.9036 |
Mainz Biomed N V Stock (MYNZ) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-14-25 | Initiated | Maxim Group | Buy |
| Nov-25-24 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Nov-21-23 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jun-21-22 | Initiated | H.C. Wainwright | Buy |
Mainz Biomed N V Stock (MYNZ) Latest News
Building trade automation scripts for Mainz Biomed N.V.July 2025 Market Mood & Stepwise Swing Trade Plans - newser.com
Will Mainz Biomed N.V. (4TO) stock benefit from mergersJuly 2025 Levels & High Accuracy Buy Signal Tips - newser.com
Will Mainz Biomed N.V. outperform the marketDollar Strength & Growth Focused Investment Plans - newser.com
Will Mainz Biomed N.V. stock remain a Wall Street favoriteQuarterly Earnings Summary & Real-Time Volume Surge Alerts - newser.com
What dividend safety score for Mainz Biomed N.V. stockFed Meeting & Community Trade Idea Sharing - Fundação Cultural do Pará
Why Mainz Biomed N.V. stock is recommended by analystsMarket Rally & AI Powered Market Entry Strategies - Fundação Cultural do Pará
How Mainz Biomed N.V. (4TO) stock performs in easing cyclesTrade Signal Summary & Long-Term Safe Investment Plans - newser.com
Is Mainz Biomed N.V. stock ready for a breakoutJuly 2025 Trends & Verified Momentum Watchlists - newser.com
Will Mainz Biomed N.V. (4TO) stock return to pre crash levelsWeekly Risk Report & Consistent Profit Alerts - newser.com
Can Mainz Biomed N.V. stock continue upward trend2025 Market Outlook & Long-Term Safe Return Strategies - newser.com
Will Mainz Biomed N.V. (4TO) stock rise with strong economyMarket Volume Summary & Expert Curated Trade Setups - newser.com
Can Mainz Biomed N.V. stock deliver strong Q4 earnings2025 Macro Impact & Real-Time Volume Analysis - newser.com
Using portfolio simulators with Mainz Biomed N.V. includedTrend Reversal & Stepwise Trade Execution Plans - newser.com
What’s the recovery path for long term holders of Mainz Biomed N.V.July 2025 WrapUp & Weekly Setup with ROI Potential - newser.com
Key resistance and support levels for Mainz Biomed N.V.Long Setup & Real-Time Stock Entry Alerts - newser.com
How forex fluctuations impact Mainz Biomed N.V. (4TO) stock2025 Fundamental Recap & Risk Controlled Stock Alerts - newser.com
Is Mainz Biomed N.V. stock affected by interest rate hikesMarket Risk Analysis & Real-Time Price Movement Reports - Fundação Cultural do Pará
What to do if you’re stuck in Mainz Biomed N.V.Profit Target & Daily Technical Stock Forecast Reports - newser.com
Is Mainz Biomed N.V. stock a safe investment in uncertain marketsMarket Movers & Advanced Swing Trade Entry Plans - newser.com
Mainz Biomed N V Stock (MYNZ) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.10%
0.32%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):